(1)
Han, G.; Gottlieb, A.; Armstrong, A.; Strober, B.; Soung, J.; Herr, H.; Davis, L.; Lebwohl, M. Bimekizumab Efficacy through Year 1 in Patients With Moderate to Severe Plaque Psoriasis Who Had Not Achieved a PASI 90 Response by Week 16: A Pooled Analysis from Four Phase 3/3B Trials. J of Skin 2024, 8, s369.